This indicates that PD-L1 expression is a mechanism for cancer to escape immune-mediated destruction (15), and PD-L1 expression on tumor and/or immune cells is associated with a better response to anti-PD-1 therapy (10, 13, 16). This evidence concerns the gene CD274 and cancer.